Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We looked at our HIVRslow progressors cohort to determine if there were any human leukocyte antigen (HLA) correlates for protection. No statistically significant allelic differences were found between the HIVRand control cohorts using regression analysis, though trendswere noted. Data for Elite Controllers showed an increased frequency of BM57. Likewise, no correlation was inferred with the clinical data of the HIVRcohort. We hypothesize that the protective effect of HLA alleles may have been lost over time. © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins.

Original publication

DOI

10.1097/QAD.0000000000000011

Type

Journal article

Journal

AIDS

Publication Date

13/11/2013

Volume

27

Pages

2822 - 2824